Inventor
Andrew Douglas Baxter
Inventor
Cambridge, GB
Overview
Patents· 58 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds11%
C07KPeptides6%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
Y02ATechnologies for adaptation to climate change2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
9,975,860Anti-angiogenic compounds20189,815,788'Anti-angiogenic compounds'20179,388,138'Anti-angiogenic compounds'20168,846,954'Crystallisation and purification of glycopyrronium bromide'20148,188,150'Use of beta-aminoalcohols in the treatment of inflammatory disorders and pain'20128,030,357'Use of bupropion metabolites for the treatment of inflammatory disorders'20117,915,303'Glycopyrronium salts and their therapeutic use'20117,902,188'Morpholine dopamine agonists'20117,728,035'Ester derivatives of rhein and their therapeutic use'20107,662,825'N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases'20107,576,081'Morpholine dopamine agonists'20097,498,338'Compounds'20097,410,972'Compounds'20087,358,376'Substituted Thiophene compounds'20087,323,462'Morpholine dopamine agonists'20087,084,145'Triazole compounds useful in therapy'20066,946,478'Compounds'20056,933,306'Hydroxamic and carboxylic acid derivatives'20056,818,622'Selective MMP inhibitors having reduced side-effects'20046,812,226'P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disease'20046,809,100'Hydroxamic acid derivatives'20046,806,273'Compounds'20046,787,536'Hydroxamic acid derivatives'20046,734,189'Hydroxamic and carboxylic acid derivatives'20046,706,719'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity'20046,680,338'Hydroxamic and carboxylic acid derivatives'20046,566,384'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity'20036,518,286'Compounds'20036,506,764'Hydroxamic and carboxylic acid derivatives'20036,506,773'Hydroxamic and carboxylic acid derivatives'20036,503,910'Hydroxamic and carboxylic acid derivatives'20036,469,020'Hydroxamic and carboxylic acid derivatives'20026,465,468'Hydroxamic and carboxylic acid derivatives'20026,462,042'Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors'20026,455,531'Hydroxamic acid derivatives'20026,310,088'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity'20016,303,659'Compounds'20016,258,838'Compounds'20016,242,470'Adamantane derivatives'20016,187,924'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity'20016,180,611'Peptidyl compounds'20016,118,001'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity'20006,114,372'Peptidyl compounds having MMP and TNF inhibitory activity'20006,110,896'Peptidyl compounds and their therapeutic use'20006,100,266'Hydroxamic and carboxylic acid derivatives'20006,090,840'Peptidyl compounds having MMP and TNF inhibitory activity'20006,063,786'Heterocyclic compounds having MMP and TNF inhibitory activity'20006,048,841'Peptidyl compounds'20005,994,293'Peptidyl compounds and their therapeutic use'19995,994,312'Peptidyl compounds'19995,981,491'Peptidyl compounds and their therapeutic use'19995,981,490'Peptidyl compounds'19995,955,435'Peptidyl compounds having MMP and TNF inhibitory activity'19995,891,878'Quinolones and their therapeutic use'19995,872,146'Mercapto alkyl peptidyl compounds having MMP and TNF inhibitory activity'19995,853,623'Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases'19985,753,666'Quinolones and their therapeutic use'19985,698,706'Heterocyclic amides and methods of use'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–1999Patents assigned to CHIROSCIENCE LTD (5)· patent assignee history
1997–2014Based in Cambridge, GB· patent location history
1999–2005Patents assigned to DARWIN DISCOVERY LTD (30)· patent assignee history
2001–2010Patents assigned to ASTRAZENECA AB (11)· patent assignee history
2001–2008Based in Wymeswold, GB· patent location history
2004–2010Based in Loughborough, GB· patent location history
2006–2011Patents assigned to PFIZER (4)· patent assignee history
2006–2011Based in Sandwich, GB· patent location history
2010–2014Patents assigned to SOSEI R & D LTD (3)· patent assignee history
2016–2017Based in West Sussex, GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DARWIN DISCOVERY LTD | 30 | 1999–2005 |
| ASTRAZENECA AB | 11 | 2001–2010 |
| CHIROSCIENCE LTD | 5 | 1997–1999 |
| PFIZER | 4 | 2006–2011 |
| SOSEI R & D LTD | 3 | 2010–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cambridge, GB | 39 | 1997–2014 |
| Wymeswold, GB | 5 | 2001–2008 |
| Sandwich, GB | 4 | 2006–2011 |
| Loughborough, GB | 4 | 2004–2010 |
| West Sussex, GB | 2 | 2016–2017 |